Andreas Halvorsen – INBX history
- Issuer:
- INHIBRX BIOSCIENCES INC
- Quarters tracked:
- 24 (Q3 2020 → Q2 2026)
- Current shares:
- 1,123,929
- Current value:
- $106.49M
- Peak shares:
- 7,150,826 (Q3 2023)
- Overall change:
- -79%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 1,123,929 | $106.49M | $94.75 | -313,776 | -22% |
| Q1 2026 | 1,437,705 | $96.66M | $67.23 | 0 | 0% |
| Q4 2025 | 1,437,705 | $113.58M | $79.00 | -350,000 | -20% |
| Q3 2025 | 1,787,705 | $60.21M | $33.68 | 0 | 0% |
| Q2 2025 | 1,787,705 | $25.51M | $14.27 | 0 | 0% |
| Q1 2025 | 1,787,705 | $25.01M | $13.99 | 0 | 0% |
| Q4 2024 | 1,787,705 | $27.53M | $15.40 | 0 | 0% |
| Q3 2024 | 1,787,705 | $28.00M | $15.66 | 0 | 0% |
| Q2 2024 | 1,787,705 | $25.33M | $14.17 | -5,363,121 | -75% |
| Q1 2024 | 7,150,826 | $249.99M | $34.96 | 0 | 0% |
| Q4 2023 | 7,150,826 | $271.73M | $38.00 | 0 | 0% |
| Q3 2023 | 7,150,826 | $131.22M | $18.35 | +511,627 | +8% |
| Q2 2023 | 6,639,199 | $172.35M | $25.96 | 0 | 0% |
| Q1 2023 | 6,639,199 | $125.28M | $18.87 | 0 | 0% |
| Q4 2022 | 6,639,199 | $163.59M | $24.64 | +1,333,333 | +25% |
| Q3 2022 | 5,305,866 | $95.24M | $17.95 | 0 | 0% |
| Q2 2022 | 5,305,866 | $60.22M | $11.35 | 0 | 0% |
| Q1 2022 | 5,305,866 | $118.22M | $22.28 | 0 | 0% |
| Q4 2021 | 5,305,866 | $231.71M | $43.67 | 0 | 0% |
| Q3 2021 | 5,305,866 | $176.74M | $33.31 | 0 | 0% |
| Q2 2021 | 5,305,866 | $146.02M | $27.52 | 0 | 0% |
| Q1 2021 | 5,305,866 | $106.49M | $20.07 | 0 | 0% |
| Q4 2020 | 5,305,866 | $174.93M | $32.97 | 0 | 0% |
| Q3 2020 | 5,305,866 | $95.51M | $18.00 | — | NEW |